A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis

In search of a mouse model for use in evaluating dengue vaccines, we assessed A129 mice that lacked IFN-α/β receptors, rendering them susceptible to dengue virus (DENV) infection. To our knowledge, no reports have evaluated dengue vaccine efficiency using A129 mice. A129 mice were given a single int...

Full description

Bibliographic Details
Main Authors: Mya Myat Ngwe Tun, Khine Mya Nwe, Jean Claude Balingit, Yuki Takamatsu, Shingo Inoue, Basu Dev Pandey, Takeshi Urano, Michinori Kohara, Kyoko Tsukiyama-Kohara, Kouichi Morita
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/12/1857
_version_ 1827573366732619776
author Mya Myat Ngwe Tun
Khine Mya Nwe
Jean Claude Balingit
Yuki Takamatsu
Shingo Inoue
Basu Dev Pandey
Takeshi Urano
Michinori Kohara
Kyoko Tsukiyama-Kohara
Kouichi Morita
author_facet Mya Myat Ngwe Tun
Khine Mya Nwe
Jean Claude Balingit
Yuki Takamatsu
Shingo Inoue
Basu Dev Pandey
Takeshi Urano
Michinori Kohara
Kyoko Tsukiyama-Kohara
Kouichi Morita
author_sort Mya Myat Ngwe Tun
collection DOAJ
description In search of a mouse model for use in evaluating dengue vaccines, we assessed A129 mice that lacked IFN-α/β receptors, rendering them susceptible to dengue virus (DENV) infection. To our knowledge, no reports have evaluated dengue vaccine efficiency using A129 mice. A129 mice were given a single intraperitoneal (IP) or subcutaneous (SC) injection of the vaccine, Dengvaxia. After 14 days of immunization via the IP or SC injection of Dengvaxia, the A129 mice exhibited notably elevated levels of anti-DENV immunoglobulin G and neutralizing antibodies (NAb) targeting all four DENV serotypes, with DENV-4 displaying the highest NAb levels. After challenge with DENV-2, Dengvaxia and mock-immunized mice survived, while only the mock group exhibited signs of morbidity. Viral genome levels in the serum and tissues (excluding the brain) were considerably lower in the immunized mice compared to those in the mock group. The SC administration of Dengvaxia resulted in lower viremia levels than IP administration did. Therefore, given that A129 mice manifest dengue-related morbidity, including viremia in the serum and other tissues, these mice represent a valuable model for investigating novel dengue vaccines and antiviral drugs and for exploring dengue pathogenesis.
first_indexed 2024-03-08T20:18:20Z
format Article
id doaj.art-a9bbcb9d0a4641adb6397d08cd477cdc
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-08T20:18:20Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-a9bbcb9d0a4641adb6397d08cd477cdc2023-12-22T14:47:36ZengMDPI AGVaccines2076-393X2023-12-011112185710.3390/vaccines11121857A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating PathogenesisMya Myat Ngwe Tun0Khine Mya Nwe1Jean Claude Balingit2Yuki Takamatsu3Shingo Inoue4Basu Dev Pandey5Takeshi Urano6Michinori Kohara7Kyoko Tsukiyama-Kohara8Kouichi Morita9Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, JapanDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, JapanDepartment of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, JapanDepartment of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, JapanKenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, JapanDejima Infectious Diseases Research Alliance, Nagasaki University, Nagasaki 852-8523, JapanCenter for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 690-8504, JapanDepartment of Diseases and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-0057, JapanTransboundary Animal Diseases Centre, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanDepartment of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, JapanIn search of a mouse model for use in evaluating dengue vaccines, we assessed A129 mice that lacked IFN-α/β receptors, rendering them susceptible to dengue virus (DENV) infection. To our knowledge, no reports have evaluated dengue vaccine efficiency using A129 mice. A129 mice were given a single intraperitoneal (IP) or subcutaneous (SC) injection of the vaccine, Dengvaxia. After 14 days of immunization via the IP or SC injection of Dengvaxia, the A129 mice exhibited notably elevated levels of anti-DENV immunoglobulin G and neutralizing antibodies (NAb) targeting all four DENV serotypes, with DENV-4 displaying the highest NAb levels. After challenge with DENV-2, Dengvaxia and mock-immunized mice survived, while only the mock group exhibited signs of morbidity. Viral genome levels in the serum and tissues (excluding the brain) were considerably lower in the immunized mice compared to those in the mock group. The SC administration of Dengvaxia resulted in lower viremia levels than IP administration did. Therefore, given that A129 mice manifest dengue-related morbidity, including viremia in the serum and other tissues, these mice represent a valuable model for investigating novel dengue vaccines and antiviral drugs and for exploring dengue pathogenesis.https://www.mdpi.com/2076-393X/11/12/1857A129 mouseDengvaxia vaccinedengue virusneutralization antibodyviral loads
spellingShingle Mya Myat Ngwe Tun
Khine Mya Nwe
Jean Claude Balingit
Yuki Takamatsu
Shingo Inoue
Basu Dev Pandey
Takeshi Urano
Michinori Kohara
Kyoko Tsukiyama-Kohara
Kouichi Morita
A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
Vaccines
A129 mouse
Dengvaxia vaccine
dengue virus
neutralization antibody
viral loads
title A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
title_full A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
title_fullStr A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
title_full_unstemmed A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
title_short A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
title_sort novel comprehensive a129 mouse model for investigating dengue vaccines and evaluating pathogenesis
topic A129 mouse
Dengvaxia vaccine
dengue virus
neutralization antibody
viral loads
url https://www.mdpi.com/2076-393X/11/12/1857
work_keys_str_mv AT myamyatngwetun anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT khinemyanwe anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT jeanclaudebalingit anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT yukitakamatsu anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT shingoinoue anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT basudevpandey anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT takeshiurano anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT michinorikohara anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT kyokotsukiyamakohara anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT kouichimorita anovelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT myamyatngwetun novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT khinemyanwe novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT jeanclaudebalingit novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT yukitakamatsu novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT shingoinoue novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT basudevpandey novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT takeshiurano novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT michinorikohara novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT kyokotsukiyamakohara novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis
AT kouichimorita novelcomprehensivea129mousemodelforinvestigatingdenguevaccinesandevaluatingpathogenesis